Brian Burkavage - 21 Nov 2023 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Role: Chief Accounting Officer
Signature: /s/ Brian Burkavage
Issuer symbol: IOBT
Transactions as of: 21 Nov 2023
Net transactions value: +$10,125
Form type: 4
Filing time: 24 Nov 2023, 17:37:11 UTC
Previous filing: 22 Mar 2023
Next filing: 18 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IOBT	Common Stock	Purchase	$4,950	+5,000	+333%	$0.9900	6,500	21 Nov 2023	Direct
transaction	IOBT	Common Stock	Purchase	$5,175	+5,000	+77%	$1.04	11,500	22 Nov 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transaction was executed in multiple trades in prices ranging from $1.03 to $1.04, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.

Content

The transaction was executed in multiple trades in prices ranging from $1.03 to $1.04, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.